Annual CFI:
-$205.60M-$180.41M(-716.36%)Summary
- As of today, MLTX annual cash from investing is -$205.60 million, with the most recent change of -$180.41 million (-716.36%) on December 31, 2024.
- During the last 3 years, MLTX annual cash from investing has fallen by -$205.54 million (-405413.41%).
- MLTX annual cash from investing is now -405413.41% below its all-time high of -$50.70 thousand, reached on December 31, 2021.
Performance
MLTX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFI:
$88.40M+$149.00K(+0.17%)Summary
- As of today, MLTX quarterly cash from investing is $88.40 million, with the most recent change of +$149.00 thousand (+0.17%) on September 30, 2025.
- Over the past year, MLTX quarterly cash from investing has increased by +$30.12 million (+51.68%).
- MLTX quarterly cash from investing is now -24.36% below its all-time high of $116.87 million, reached on December 31, 2023.
Performance
MLTX Quarterly Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$85.57M+$30.12M(+54.32%)Summary
- As of today, MLTX TTM cash from investing is $85.57 million, with the most recent change of +$30.12 million (+54.32%) on September 30, 2025.
- Over the past year, MLTX TTM cash from investing has increased by +$26.97 million (+46.02%).
- MLTX TTM cash from investing is now at all-time high.
Performance
MLTX TTM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
MLTX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -716.4% | +51.7% | +46.0% |
| 3Y3 Years | -10000.0% | +309.4% | +302.5% |
| 5Y5 Years | -78.8% | - | - |
MLTX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | >-9999.0% | at low | -24.4% | +150.7% | at high | +141.6% |
| 5Y | 5-Year | >-9999.0% | at low | -24.4% | +150.7% | at high | +141.6% |
| All-Time | All-Time | >-9999.0% | at low | -24.4% | +150.7% | at high | +141.6% |
MLTX Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $88.40M(+0.2%) | $85.57M(+54.3%) |
| Jun 2025 | - | $88.25M(+56.9%) | $55.45M(+146.0%) |
| Mar 2025 | - | $56.25M(+138.2%) | -$120.55M(+41.4%) |
| Dec 2024 | -$205.60M(-716.4%) | -$147.33M(-352.8%) | -$205.60M(-450.8%) |
| Sep 2024 | - | $58.28M(+166.4%) | $58.60M(+133.7%) |
| Jun 2024 | - | -$87.74M(-204.6%) | -$174.06M(-136.4%) |
| Mar 2024 | - | -$28.80M(-124.6%) | -$73.64M(-192.4%) |
| Dec 2023 | -$25.18M | $116.87M(+167.0%) | -$25.18M(+80.9%) |
| Sep 2023 | - | -$174.38M(-1475.6%) | -$132.15M(>-9900.0%) |
| Jun 2023 | - | $12.68M(-35.5%) | $0.00(+100.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $19.65M(+98.4%) | -$12.68M(+60.8%) |
| Dec 2022 | -$32.34M(>-9900.0%) | $9.90M(+123.4%) | -$32.34M(+23.5%) |
| Sep 2022 | - | -$42.23M(>-9900.0%) | -$42.26M(>-9900.0%) |
| Jun 2022 | - | $0.00(+100.0%) | -$46.00K(+31.0%) |
| Mar 2022 | - | -$16.00K(+13.0%) | -$66.70K(-31.6%) |
| Dec 2021 | -$50.70K(+100.0%) | -$18.40K(-58.6%) | -$50.70K(+100.0%) |
| Sep 2021 | - | -$11.60K(+44.0%) | -$115.03M(-0.0%) |
| Jun 2021 | - | -$20.70K(>-9900.0%) | -$115.02M(-0.0%) |
| Mar 2021 | - | $0.00(+100.0%) | -$115.00M(0.0%) |
| Dec 2020 | -$115.00M | -$115.00M | -$115.00M |
FAQ
- What is MoonLake Immunotherapeutics annual cash from investing?
- What is the all-time high annual cash from investing for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual cash from investing year-on-year change?
- What is MoonLake Immunotherapeutics quarterly cash from investing?
- What is the all-time high quarterly cash from investing for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly cash from investing year-on-year change?
- What is MoonLake Immunotherapeutics TTM cash from investing?
- What is the all-time high TTM cash from investing for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM cash from investing year-on-year change?
What is MoonLake Immunotherapeutics annual cash from investing?
The current annual cash from investing of MLTX is -$205.60M
What is the all-time high annual cash from investing for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual cash from investing is -$50.70K
What is MoonLake Immunotherapeutics annual cash from investing year-on-year change?
Over the past year, MLTX annual cash from investing has changed by -$180.41M (-716.36%)
What is MoonLake Immunotherapeutics quarterly cash from investing?
The current quarterly cash from investing of MLTX is $88.40M
What is the all-time high quarterly cash from investing for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly cash from investing is $116.87M
What is MoonLake Immunotherapeutics quarterly cash from investing year-on-year change?
Over the past year, MLTX quarterly cash from investing has changed by +$30.12M (+51.68%)
What is MoonLake Immunotherapeutics TTM cash from investing?
The current TTM cash from investing of MLTX is $85.57M
What is the all-time high TTM cash from investing for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM cash from investing is $85.57M
What is MoonLake Immunotherapeutics TTM cash from investing year-on-year change?
Over the past year, MLTX TTM cash from investing has changed by +$26.97M (+46.02%)